Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: test procedure meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Principles of method if other than guideline:
original language: German
GLP compliance:
no
Test type:
other: following old standard method

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4',4''-methylidynetrianiline
EC Number:
208-952-0
EC Name:
4,4',4''-methylidynetrianiline
Cas Number:
548-61-8
Molecular formula:
C19H19N3
IUPAC Name:
4,4',4''-methylidynetrianiline

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 7-9 weeks
- Weight at study initiation: mean males 172 g, mean females 161 g
- Fasting period before study: approximately 16 hours
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: water and cremophor
Doses:
1000, 1500, 1750, 2000, 2500, 3000, 3500, and 5000 mg/kg bw
No. of animals per sex per dose:
10 males/dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 21 days
- Observation for clinical signs and mortality, feces
- Frequency of weighing: before administration, after one week and et the end of the 14-day observation period
Statistics:
Probit-Analysis (Fink and Hund, Arzneimittelforschung 15, 624, 1965)

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Remarks on result:
other: Probit-Analysis revealed an LD50 of 2057 mg/kg
Mortality:
1000 mg/kg: 0/10
1500 mg/kg: 2/10
1750 mg/kg: 4/10
2000 mg/kg: 5/10
2500 mg/kg: 6/10
3000 mg/kg: 9/10
3500 mg/kg: 9/10
5000 mg/kg: 10/10
Clinical signs:
general bad condition
Body weight:
reduced at 3500 and 5000 mg/kg bw
Other findings:
brown-red feces, increased water consumption and elimination

Applicant's summary and conclusion

Conclusions:
LD50 was calculated to be greater than 2000 mg/kg bw
Executive summary:

The acute oral toxicity of the test item was evaluated in a study on male Wistar rats. Single oral doses of 1000 to 5000 mg/kg bw were given to groups of 10 male rats. Mortality occurred at doses of 1500 mg/kg bw and above. The LD50 of the test item was calculated with 2057 mg/kg bw and thus is > 2000 mg/kg bw. According to EU Regulation 1272/2008 no classification for acute oral toxicity is warranted.